Dair approach in 7 infected total hip arthroplasties: our experience and current concepts of the literature

Introduction: Periprosthetic joint infection (PJI) is one of the most challenging complications following total hip arthroplasty. In early infection, within four to twelve weeks from surgery, debridement, antibiotics and implant retention (DAIR) can be the initial treatment. The aim of this study is to report our case series and review current concepts reported in the literature about this topic. Materials and Methods: This was an observational cohort study that included 7 patients managed with DAIR for PJI following primary total hip replacement (THR) between 2014 and 2020. Inclusion criteria were a primary THR, direct anterior or lateral approach, DAIR procedure, and PJI. Exclusion criteria were a PJI following a revision total hip replacement or hemiarthroplasty, posterolateral approach, 1-stage revision, 2-stage revision, and Girdlestone procedure without prior DAIR. For each patient demographic characteristics, laboratory values, microorganisms involved, antibiotic therapy and outcome at one-year follow-up were registered. Results: The mean duration between THR and DAIR was 19 days. In all cases only one DAIR procedure was performed. Most infections were caused by Staphylococcus aureus (4 cases) [one methicillin resistant (MRSA)]. The other infections were caused by Streptococcus agalactiae, Staphylococcus coagulase negative and Escherichia coli. At the final follow-up, the procedure was considered as successful in 6 out of 7 patients (85%). The one with unsuccessful outcome underwent to a two-stage revision. Discussion: Our results were comparable with those of a recent systematic review of the literature. Factors that have been postulated to influence the outcome of DAIR in the management of PJIs include the timing and numbers of debridement, the exchange of components, the responsible microorganism and the duration of antibiotic treatment. In conclusion, the outcomes following DAIR are better as the indications are refined and risk factors identified. PJI prevention remains the key but the current literature still lacks well documented and effective PJI prevention protocols. (www.actabiomedica.it)

[1]  E. Vaienti,et al.  Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years , 2020, Acta bio-medica : Atenei Parmensis.

[2]  J. Kärrholm,et al.  Exchange of Modular Components Improves Success of Debridement, Antibiotics, and Implant Retention , 2020, JB & JS open access.

[3]  B. Pijls,et al.  Debridement, Antibiotics, and Implant Retention with the Direct Anterior Approach for Acute Periprosthetic Joint Infection Following Primary THA , 2020, JB & JS open access.

[4]  M. (. van der Steen,et al.  Optimization of the empirical antibiotic choice during the treatment of acute prosthetic joint infections: a retrospective analysis of 91 patients , 2019, Acta orthopaedica.

[5]  E. Vaienti,et al.  Outcome of short versus conventional stem for total hip arthroplasty in the femur with a high cortical index: a five year follow-up prospective multicentre comparative study , 2019, International Orthopaedics.

[6]  M. Leigheb,et al.  When is indicated viscosupplementation in hip osteoarthritis? , 2018, Acta bio-medica : Atenei Parmensis.

[7]  M. Loppini,et al.  Double-trabecular metal cup technique for the management of Paprosky type III defects without pelvic discontinuity , 2018, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[8]  M. Buttaro,et al.  State-of-the-art diagnosis and surgical treatment of acute peri-prosthetic joint infection following primary total hip arthroplasty , 2018, EFORT open reviews.

[9]  M. Varacallo,et al.  Joint perception and patient perceived satisfaction after total hip and knee arthroplasty in the American population. , 2018, Journal of orthopaedics.

[10]  Frank A. Liporace,et al.  Strategies for Management of Periprosthetic Joint Infection. , 2018, Bulletin of the Hospital for Joint Disease.

[11]  A. Simpson,et al.  Outcomes following debridement, antibiotics and implant retention in the management of periprosthetic infections of the hip: A REVIEW OF COHORT STUDIES , 2017, The bone & joint journal.

[12]  Philip Kinghorn,et al.  Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature , 2017, BMC Musculoskeletal Disorders.

[13]  D. Murray,et al.  Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: A CASE‐CONTROL STUDY , 2017, The bone & joint journal.

[14]  W. Zimmerli,et al.  Debridement and implant retention in the management of hip periprosthetic joint infection: OUTCOMES FOLLOWING GUIDED AND RAPID TREATMENT AT A SINGLE CENTRE , 2017, The bone & joint journal.

[15]  S. Young,et al.  Antibiotic resistance in early periprosthetic joint infection , 2016, ANZ journal of surgery.

[16]  S. Kurtz,et al.  Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA , 2015, Clinical orthopaedics and related research.

[17]  D. Suvà,et al.  Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus , 2015, International Orthopaedics.

[18]  E. Peters,et al.  Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention) , 2013, Acta orthopaedica.

[19]  J. Parvizi,et al.  Failure of Irrigation and Débridement for Early Postoperative Periprosthetic Infection , 2013, Clinical orthopaedics and related research.

[20]  P. Choong,et al.  Outcome of Debridement and Retention in Prosthetic Joint Infections by Methicillin-Resistant Staphylococci, with Special Reference to Rifampin and Fusidic Acid Combination Therapy , 2012, Antimicrobial Agents and Chemotherapy.

[21]  C. Romanò,et al.  Value of Debridement and Irrigation for the Treatment of Peri-Prosthetic Infections. A Systematic Review , 2012, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

[22]  J. Parvizi,et al.  Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection. , 2012, The Journal of bone and joint surgery. American volume.

[23]  Carles Amat Mateu,et al.  Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. , 2012, The Journal of antimicrobial chemotherapy.

[24]  J. Parvizi,et al.  Prosthetic joint infection caused by gram-negative organisms. , 2011, The Journal of arthroplasty.

[25]  S. Klouche,et al.  Infected total hip arthroplasty treated by an irrigation-debridement/component retention protocol. A prospective study in a 12-case series with minimum 2 years' follow-up. , 2011, Orthopaedics & traumatology, surgery & research : OTSR.

[26]  Jacob T. Munro,et al.  Infection in total hip replacement: meta-analysis , 2011, International Orthopaedics.

[27]  R. Sousa,et al.  Empirical antibiotic therapy in prosthetic joint infections. , 2010, Acta orthopaedica Belgica.

[28]  C. Beauchamp,et al.  A Two-stage Retention Débridement Protocol for Acute Periprosthetic Joint Infections , 2010, Clinical orthopaedics and related research.

[29]  Mel S. Lee,et al.  Gram-negative prosthetic joint infections: risk factors and outcome of treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  P. Bejon,et al.  One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome , 2009, The Journal of antimicrobial chemotherapy.

[31]  R. Andersen,et al.  Prosthesis retention, serial debridement, and antibiotic bead use for the treatment of infection following total joint arthroplasty. , 2009, Orthopedics.

[32]  E. Moran,et al.  Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. , 2007, The Journal of infection.

[33]  Brent T. Wise,et al.  Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. , 2006, The Journal of bone and joint surgery. American volume.

[34]  G. Saunders.  Methicillin resistant Staphylococcus aureus. , 2006, The West Indian medical journal.

[35]  A. Hanssen,et al.  Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  D. Kilgus,et al.  Results of Periprosthetic Hip and Knee Infections Caused by Resistant Bacteria , 2002, Clinical orthopaedics and related research.

[37]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[38]  C. König,et al.  Factors Compromising Antibiotic Activity Against Biofilms of Staphylococcus epidermidis , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[39]  Claude Carbón,et al.  Prosthetic joint infection: when can prosthesis salvage be considered? , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[41]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[42]  A. Hanssen,et al.  Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  R. Gustilo,et al.  Infection after Total Hip Arthroplasty. A Study of the Treatment of One Hundred and Six Infections* , 1996, The Journal of bone and joint surgery. American volume.

[44]  D. Raoult,et al.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants , 1993, Antimicrobial Agents and Chemotherapy.

[45]  C. Perry,et al.  Treatment of acutely infected arthroplasties with incision, drainage, and local antibiotics delivered via an implantable pump. , 1992, Clinical orthopaedics and related research.

[46]  A. Widmer,et al.  Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  J. Costerton,et al.  Bacterial adherence and the glycocalyx and their role in musculoskeletal infection , 1984, The Orthopedic clinics of North America.

[48]  E. Vaienti,et al.  When is indicated fibular fixation in extra-articular fractures of the distal tibia? , 2019, Acta bio-medica : Atenei Parmensis.

[49]  T. Peel,et al.  Prosthetic Joint Infections , 2018, Springer International Publishing.

[50]  M. Whitehouse,et al.  Deep infection after hip arthroplasty: staying current with change. , 2016, The bone & joint journal.

[51]  D. Moojen.  Similar success rates for single and multiple debridement surgery for acute hip arthroplasty infection--reply. , 2015, Acta orthopaedica.

[52]  P Stoodley,et al.  Survival strategies of infectious biofilms. , 2005, Trends in microbiology.

[53]  M. B. Coventry.  Treatment of infections occurring in total hip surgery. , 1975, The Orthopedic clinics of North America.